Virtus Lifesci Biotech Clinical Trials ETF (BBC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BBC | VHT | XBI | ||
| Company | Virtus Lifesci Biotech Clinical Trials ETF | Healthcare ETF Vanguard | S&P Biotech SPDR | ||
| Price Information | |||||
| Exchange | NYSE Arca | NYSE Arca | NYSE Arca | ||
| Open | 48.84 | 312.67 | 149.23 | ||
| High | 49.14 | 314.42 | 151.11 | ||
| Low | 48.02 | 312.40 | 147.04 | ||
| Latest | 48.02 | 313.77 | 147.23 | ||
| Change | -0.83 | +0.54 | -2.55 | ||
| % Change | -1.69% | +0.17% | -1.70% | ||
| Volume | 2,493 | 68,528 | 2,985,584 | ||
| 20-Day Average Volume | 28,443 | 246,492 | 8,410,159 | ||
| Previous Close | 48.85 | 313.23 | 149.78 | ||
| Industry | N/A | N/A | Finance - Investment Funds | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 51.37 | 304.69 | 155.48 | ||
| 20-Day Raw Stochastic | 4.64% | 95.19% | 4.15% | ||
| 20-Day Relative Strength | 47.77 | 65.97 | 48.84 | ||
| Weighted Alpha | +103.24 | +29.35 | +63.93 | ||
| Today's Opinion | 88% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 88% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 56% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.82% since 07/22/26 | +4.74% since 07/22/26 | -2.83% since 07/22/26 | ||
| Low | 47.84 on 07/28/26 | 299.71 on 07/23/26 | 147.04 on 07/29/26 | ||
| High | 50.70 on 07/27/26 | 314.90 on 07/28/26 | 154.21 on 07/27/26 | ||
| 1-Month | |||||
| %Chg | -8.33% since 06/29/26 | +3.83% since 06/29/26 | -6.63% since 06/29/26 | ||
| Low | 47.84 on 07/28/26 | 296.39 on 07/21/26 | 147.04 on 07/29/26 | ||
| High | 54.95 on 07/09/26 | 314.90 on 07/28/26 | 165.71 on 07/09/26 | ||
| 3-Month | |||||
| %Chg | +12.52% since 04/29/26 | +17.69% since 04/29/26 | +14.67% since 04/29/26 | ||
| Low | 40.03 on 06/09/26 | 267.33 on 05/11/26 | 125.07 on 05/19/26 | ||
| High | 54.95 on 07/09/26 | 314.90 on 07/28/26 | 165.71 on 07/09/26 | ||
| 6-Month | |||||
| %Chg | +16.07% since 01/29/26 | +9.76% since 01/29/26 | +16.62% since 01/29/26 | ||
| Low | 38.63 on 03/30/26 | 264.97 on 03/27/26 | 118.19 on 03/24/26 | ||
| High | 54.95 on 07/09/26 | 314.90 on 07/28/26 | 165.71 on 07/09/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 46,405 | 18,643,450 | 9,848,035 | ||
| Shares Outstanding, K | 950 | 59,520 | 65,750 | ||
| Annual Sales | 0 | 0 | 0 | ||
| Annual Net Income | 0 | 0 | 0 | ||
| Last Quarter Sales | N/A | N/A | N/A | ||
| Last Quarter Net Income | N/A | N/A | N/A | ||
| 60-Month Beta | 0.86 | 0.60 | 0.82 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | N/A | N/A | ||
| Earnings Date | N/A | N/A | N/A | ||
| Most Recent Dividend | 0.655 on 12/22/25 | 0.987 on 06/24/26 | 0.138 on 06/22/26 | ||
| Next Ex-Dividends Date | 12/22/25 | 06/24/26 | 06/22/26 | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 27.30 | 19.11 | ||